TickerFactsScreenerDevelopers

Aquestive Therapeutics, Inc. (AQST) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: $5.82M2018: -$12.99M2019: -$60.21M2020: -$45.46M2021: -$32.98M2022: -$9.82M2023: -$6.38M2024: -$35.76M2025: -$52.43M-$52.43M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$52.43M-46.6%
2024-$35.76M-460.5%
2023-$6.38M+35.0%
2022-$9.82M+70.2%
2021-$32.98M+27.5%
2020-$45.46M+24.5%
2019-$60.21M-363.5%
2018-$12.99M-323.1%
2017$5.82M—